Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (522)	10/24/2001 10:58:34 AM
From: Biomaven	Read Replies (1) \| Respond to of 555

<<CVTX>> I'm long. I agree with Miljenko that acceptance of a late-breaker abstract likely means the trial wasn't a bust. I continue to believe that the trial extension implied nothing about the chance of success. Peter

To: Miljenko Zuanic who wrote (522)	11/5/2001 12:26:08 PM
From: rkrw	Read Replies (1) \| Respond to of 555

At the early Sept BC conference, questions were raised regarding when they would reveal results once results were known---i.e. this is highly material info, when will you announce results? CV response was that they expected to PR top line results late OCT/early NOV, with late breaker at AHA (mid nov) to present results. Here we are with no results disclosed to date. I'm trying to figure out, if they wait till AHA to disclose and present, should that be taken as a good sign, or bad sign??? Put off bad news, or it's solidly positive, let's wait until we have a captive audience??? Since the AHA late breaker status was acknowledged at BC before results would have been known, I'm not sure late breaker status necessarily means a positive outcome. Maybe you scientists would know better.